INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: Yes, for EGFR mutation analysis, others, I PASS

Research output: Contribution to journalEditorial

12 Scopus citations
Original languageEnglish
Pages (from-to)713-715
Number of pages3
JournalJournal of Clinical Oncology
Issue number5
StatePublished - Feb 10 2010

Cite this